Overall, the authors conclude that: The recognition that several gastrointestinal hormones, released in response to nutritional stimuli are important regulators of appetite (PYY, oxyntomodulin, GLP-1 and decreased secretion of ghrelin), offers a strategy for the development of more effective ant-iobesity agents.treatment of obesity could involved a combination of hormones, e.g
Our experienced healthcare providers at LCS Medical Spa take the time to carefully evaluate each clients medical history, treatment objectives, and individual needs
A growing body of research suggests that GLP-1 medications may do more than suppress appetite and reduce weight
You can track meals, macros, water intake, and activity so you see exactly how your choices support your goals
Discontinuation typically results in appetite return and weight regain, so lower BMI patients should enter treatment with realistic expectations about duration and maintenance
Liraglutide acts faster but requires daily dosing, while tirzepatide targets an additional hormone pathway that may make it more potent for weight loss
